WuXi Biologics Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market

▤ Summary

WuXi Biologics says its Suzhou Biosafety Testing Center passed its fourth EMA GMP inspection with zero critical findings. The certification supports EU marketing authorization work for 19 biologics from 13 clients. The facility provides biosafety testing, release testing, and viral clearance services across biologics development and commercialization. The update highlights the company’s regulatory track record and its role in helping clients bring biologic products to market in Europe.

▦ Linked Companies